Cite
MLA Citation
Caroline Dutriaux et al.. “An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases.” European journal of cancer, vol. 175, 2022, pp. 254–262. http://access.bl.uk/ark:/81055/vdc_100168343140.0x00001f